KOCAA
OXFD

Knights of Columbus Asset Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-109,090
Closed -$1.01M – 423
2020
Q1 		$1.01M Sell
109,090
-19,831
-15% -$277K 0.13% 240
2019
Q4 		$2.14M Buy
+128,921
New +$2.09M 0.19% 175

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Knights of Columbus Asset Advisors's OXFD Position: Q2 2020 in Review

Knights of Columbus Asset Advisors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2020, closing a stake of 109,090 shares — an estimated $1.01M sold.

Knights of Columbus Asset Advisors first reported a position in OXFD in Q4 2019 and held it in 2 quarters. The position peaked at $2.14M in Q4 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q2 2020.

  • Knights of Columbus Asset Advisors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2020 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 109,090 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2020, an estimated $1.01M.
  • Knights of Columbus Asset Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2019 and held it in 2 quarters.
  • Knights of Columbus Asset Advisors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.14M in Q4 2019.
  • 65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2020.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.